First UK patients enroll in Phase 3 clinical trials of LMTX™ for Alzheimer’s Disease

May 22 - 2013 01:00 PM
Clinical trials get under way in the UK with a second?generation tau aggregation inhibitor (TAI) aimed at halting the progression of Alzheimer’s
Read more

TauRx Chairman Highlights Future Consequences of Alzheimer’s in Asia

Apr 22 - 2013 02:00 PM
Demographic and societal impact of Alzheimer’s in China will grow exponentially if its current course is not averted, according to pioneer in tau pathology, a hallmark of Alzheimer’s Disease A new treatment targeting tau pathology is tomorrow’s hope for a brighter future, and Phase 3 clinical studies are bringing us closer to that goal.
Read more

TauRx Pharmaceuticals Receives $10.5m Follow-On Investment

Mar 04 - 2013 06:00 AM
Dundee Corporation maintains 5% stake in company developing a revolutionary treatment for Alzheimer’s Disease.
Read more

Conference in Warsaw to Spotlight TauRx

Jan 17 - 2013 01:30 PM
Major Conference in Poland will Spotlight TauRx Therapeutics as an Example of International Entrepreneurial Success in Life Science
Read more

TauRx Completes Recruitment to Phase 3 Alzheimer’s Disease Studies

Nov 20 - 2012 10:00 AM
Read more